PET Scans Could Identify Those Likely to Respond to PD-1-targeted Cancer Therapies – Immuno-Oncology News
Immuno-Oncology News |
PET Scans Could Identify Those Likely to Respond to PD-1-targeted Cancer Therapies
Immuno-Oncology News PET scans could be a non-invasive way to identify patients likely to respond to cancer therapies targeting the PD-1 and PD-L1 proteins. Bristol-Myers Squibb developed the approach. It allows scientists to see tumors bearing PD-L1, a biomarker of … |
